Home » Newsletters » BioWorld Science

BioWorld Science

June 15, 2015

View Archived Issues

Isis Pharmaceuticals updates on phase II trial of ISIS-SMNRx in infants with type I SMA

Tioga Pharmaceuticals begins phase II study of asimadoline in patients with pruritus

NCCN receives funding from Boehringer Ingelheim to study afatinib combinations in NSCLC

Merrimack expands MM-398 imaging study to patients with metastatic breast cancer

Adamas starts phase II trial of amantadine ER in patients with MS and walking impairment

Immune Pharmaceuticals licenses topical ciclosporin formulation from Yissum

Johnson & Johnson announces multiple collaborations

First preclinical data presented on ORM-23048 for neuropathic pain

Bristol-Myers Squibb patents EZH2 inhibitors

Canadian scientists describe withanolide analogues

Pharmakea discloses autotaxin inhibitors

Tolerability and activity assessed with ASP-2215 in patients with acute myeloid leukemia

PTC Therapeutics develops BMI-1 inhibitors

Daiichi Sankyo divulges LCAT activators

Novel DNA vaccine shows promising preclinical efficacy

New antibody for IBD tested at Sumitomo Dainippon Pharma

FDA awards breakthrough therapy designation to SER-109

Novel Nanofitin targeting TNF-alpha for IBD

Cancer vaccine developer Targovax merges with oncolytic virus firm Oncos

First phase I/II data for Delta-Fly Pharma's DFP-10917 in acute myeloid leukemia

KemPharm reports data from abuse liability trial of KP-201/acetaminophen

Servier licenses European rights to Taiho's TAS-102

BioAtla receives equity investment from Chinese investor group

Roswell Park Cancer Institute spins out OmniSeq

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...